Structural design and site-specific conjugation in bispecific ADCs
Bioconjugate Insights · 29.04.2026 · 1 (3) · 111–115
DOI: 10.18609/bci.2026.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Insights, online erschienen am 29.04.2026. Verfasst von Sarka Stehlikova. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
“...we know that the specificity of our antibodies and their controlled conjugation helps us target tumor tissue while avoiding engagement with healthy tissues...”Lauren Coyle, Launch Commissioning Editor, Bioconjugate Insights, speaks with Sarka Stehlikova, Director, Biologics Core Technologies, SOTIO, about the design of bispecific ADCs for addressing tumor heterogeneity. They discuss the importance of site-specific conjugation and DAR control, and how precise payload placement influences stability and safety in complex ADC architectures.
Zitieren
APA
Stehlikova, S. (2026). Structural design and site-specific conjugation in bispecific ADCs. Bioconjugate Insights, 1(3), 111–115. https://doi.org/10.18609/bci.2026.015
Vancouver
Stehlikova S. Structural design and site-specific conjugation in bispecific ADCs. Bioconjugate Insights. 2026;1(3):111–115. doi:10.18609/bci.2026.015
BibTeX
@article{Stehlikova2026,
author = {Stehlikova, Sarka},
title = {Structural design and site-specific conjugation in bispecific ADCs},
journal = {Bioconjugate Insights},
year = {2026},
volume = {1},
number = {3},
pages = {111–115},
doi = {10.18609/bci.2026.015}
}
EUVIMED